Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) had its target price raised by research analysts at JPMorgan Chase & Co. from $39.00 to $41.00 in a report released on Wednesday, Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s target price suggests a potential upside of 10.74% from the company’s current price.
Several other equities analysts have also issued reports on the company. Piper Sandler restated an “overweight” rating on shares of Keurig Dr Pepper in a research report on Wednesday, October 14th. Weiss Ratings reiterated a “hold (c)” rating on shares of Keurig Dr Pepper in a research report on Friday, August 7th. Barclays lifted their price objective on shares of Keurig Dr Pepper from $36.00 to $38.00 and gave the stock an “overweight” rating in a research note on Monday, August 10th. BNP Paribas Exane boosted their price objective on shares of Keurig Dr Pepper from $28.00 to $29.00 and gave the company a “neutral” rating in a report on Monday, August 10th. Finally, UBS Group upped their target price on shares of Keurig Dr Pepper from $38.00 to $39.00 and gave the company a “buy” rating in a research note on Friday, August 7th. Ten research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $36.76.
Get Our Latest Research Report on Keurig Dr Pepper
Keurig Dr Pepper Trading Up 6.6%
Keurig Dr Pepper stock traded up $2.28 during trading hours on Wednesday, reaching $37.02. 16,214,026 shares of the company’s stock traded hands, compared to its average volume of 12,239,366. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.28 and a current ratio of 0.48. Keurig Dr Pepper has a fifty-two week low of $24.88 and a fifty-two week high of $37.31. The firm has a market capitalization of $50.38 billion, a price-to-earnings ratio of 37.36, a PEG ratio of 1.75 and a beta of 0.35. The firm’s 50 day moving average is $32.58 and its 200-day moving average is $30.07.
Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last posted its quarterly earnings results on Tuesday, November 3rd. The company reported $0.66 earnings per share for the quarter, topping analysts’ consensus estimates of $0.62 by $0.04. Keurig Dr Pepper had a net margin of 7.10% and a return on equity of 10.80%. The business had revenue of $7.34 billion during the quarter, compared to the consensus estimate of $7.33 billion. During the same period in the previous year, the firm posted $0.54 earnings per share. Keurig Dr Pepper’s revenue for the quarter was up 70.6% compared to the same quarter last year. On average, analysts predict that Keurig Dr Pepper will post 2.30 earnings per share for the current year.
Insider Buying and Selling at Keurig Dr Pepper
In other Keurig Dr Pepper news, insider Mary Beth Denooyer sold 12,000 shares of the stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $32.55, for a total value of $390,600.00. Following the completion of the sale, the insider directly owned 84,171 shares in the company, valued at $2,739,766.05. This represents a 12.48% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Angela Stephens sold 9,500 shares of the firm’s stock in a transaction dated Thursday, September 3rd. The stock was sold at an average price of $32.70, for a total value of $310,650.00. Following the sale, the vice president directly owned 55,786 shares in the company, valued at approximately $1,824,202.20. This represents a 14.55% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.34% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of the stock. BlackRock Inc. acquired a new position in shares of Keurig Dr Pepper in the second quarter valued at approximately $4,697,645,000. Barrow Hanley Mewhinney & Strauss LLC bought a new position in shares of Keurig Dr Pepper during the second quarter worth approximately $767,105,000. Bank of America Corp DE acquired a new stake in Keurig Dr Pepper during the 2nd quarter worth approximately $281,503,000. Legal & General Group Plc acquired a new stake in Keurig Dr Pepper during the 2nd quarter worth approximately $269,336,000. Finally, Dimensional Fund Advisors LP boosted its stake in Keurig Dr Pepper by 1.1% in the 1st quarter. Dimensional Fund Advisors LP now owns 9,585,791 shares of the company’s stock valued at $252,408,000 after purchasing an additional 103,505 shares during the period. Institutional investors own 93.99% of the company’s stock.
Key Keurig Dr Pepper News
Here are the key news stories impacting Keurig Dr Pepper this week:
- Positive Sentiment: KDP reported third-quarter adjusted EPS of $0.66, above analyst estimates, while net sales reached $7.34 billion, up about 70% year over year, largely reflecting the JDE Peet’s acquisition. The company reaffirmed its full-year 2026 guidance. KDP Q3 results and guidance
- Positive Sentiment: Growth was particularly strong in beverages: energy-drink market share topped 10%, and U.S. refreshment beverage sales increased. The company’s energy portfolio and brands such as Dr Pepper Zero Sugar helped support momentum. Long-term investor takeaways
- Positive Sentiment: Morgan Stanley raised its price target to $40 and maintained an Overweight rating; Piper Sandler also lifted its target, to $41. The higher targets signal continued analyst optimism. Morgan Stanley ratings Piper Sandler price target
- Neutral Sentiment: KDP is preparing to separate its beverage and coffee businesses in early 2027. The potential restructuring may sharpen investor focus on each business, though execution and market conditions remain factors. 2026 sales outlook and planned separation
- Negative Sentiment: The coffee business faces pressure as price-sensitive shoppers trade down to cheaper options. Management lowered its legacy EPS growth outlook, making beverage growth and JDE Peet’s contribution more important to the overall story. Coffee profit and consumer trading-down report
Keurig Dr Pepper Company Profile
Keurig Dr Pepper Inc (NASDAQ: KDP) is a beverage company that operates across coffee and packaged beverages. Its portfolio includes soft drinks, flavored waters, juices, juice drinks, ready-to-drink teas and coffees, sports and energy beverages, and mixers, as well as single-serve coffee brewing systems and pods.
The company’s brands include Keurig, Green Mountain Coffee Roasters, The Original Donut Shop, Dr Pepper, Canada Dry, Snapple, 7UP, A&W, Mott’s, Bai, CORE Hydration and Venom, among others.
Further Reading
- Five stocks we like better than Keurig Dr Pepper
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.
